About the Product

Description


Pifetol 200 Tablet contains Pirfenidone 200 mg, an anti-fibrotic and anti-inflammatory agent used to manage idiopathic pulmonary fibrosis (IPF). It helps slow the progression of lung scarring, improving patients’ quality of life and pulmonary function.

Belonging to the pulmonology and anti-fibrotic segment, Pirfenidone is prescribed by pulmonologists for patients diagnosed with chronic fibrotic lung conditions. Its efficacy in reducing fibrosis makes it a critical therapy in specialized respiratory care centers.

The tablet works by modulating inflammatory mediators and fibroblast activity, which slows the development of fibrotic tissue in the lungs, supporting long-term respiratory health.

For PCD pharma franchise partners, wholesalers, exporters, and third-party manufacturers, Pifetol 200 Tablet provides a profitable B2B opportunity, catering to hospitals, clinics, and specialized pulmonology units across India.

Common side effects include nausea, vomiting, loss of appetite, rash, fatigue, and dizziness. Rare but serious side effects may include liver enzyme elevation, photosensitivity reactions, or severe allergic reactions. Seek medical attention if you experience jaundice, persistent nausea, or severe skin reactions.

Pifetol 200 Tablet is indicated for the treatment of idiopathic pulmonary fibrosis (IPF). It helps reduce the decline in lung capacity, improves exercise tolerance, and manages symptoms such as shortness of breath and chronic cough associated with lung scarring.

Take Pifetol 200 Tablet exactly as prescribed, preferably with food to reduce gastrointestinal discomfort. Avoid direct sunlight and use protective measures such as sunscreen. Inform your doctor if you have liver or kidney disorders, or are taking other medications that may affect liver function.

Store Pifetol 200 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pirfenidone IP 200mg Tablet in the PCD pharma franchise market?

Pirfenidone IP 200mg Tablet has growing demand in the pulmonology, respiratory care, and specialty medicine segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on advanced respiratory and chronic care portfolios.

Why should medical distributors include Pirfenidone IP 200mg Tablet in their product range?

Medical distributors and agencies can benefit from demand for specialized respiratory disorder management under expert medical supervision. Pirfenidone IP 200mg is an antifibrotic medication used in respiratory care Commonly prescribed for the management of Idiopathic Pulmonary Fibrosis (IPF) and certain fibrotic lung conditions as advised by healthcare professionals Helps slow the progression of lung fibrosis and supports preservation of lung function in appropriate patients Provides an established dosage strength suitable for dose titration and individualized treatment plans Oral tablet formulation offers convenient administration for long-term therapy under physician supervision Requires regular clinical monitoring, liver function assessment, and ongoing medical evaluation Frequently utilized in pulmonology clinics, specialty respiratory centers, hospitals, and tertiary healthcare facilities Widely prescribed by pulmonologists and respiratory medicine specialists This strengthens a comprehensive respiratory and specialty care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pirfenidone IP 200mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialty healthcare market opportunities, consistent prescription demand, repeat purchases, reliable supply chain support, and attractive margins in the respiratory care segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.